{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:48:01Z","timestamp":1762980481981,"version":"3.41.2"},"reference-count":18,"publisher":"Cardiofront, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.4022\/jafib.1502","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T18:30:55Z","timestamp":1513017055000},"source":"Crossref","is-referenced-by-count":4,"title":["Amiodarone-Induced Third Degree Atrioventricular Block and Extreme QT Prolongation Generating Torsade Des Pointes in Paroxysmal Atrial Fibrillation"],"prefix":"10.4022","volume":"9","author":[{"given":"Orlando Robert","family":"Sequeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson Javier","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy Beatriz","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Beatriz","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar A","family":"Lovera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osmar Antonio","family":"Centuri\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2440","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"key_R01","first-page":"484","article-title":"Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?","volume-title":"Heart Rhythm","year":"2006"},{"key":"key_R02","first-page":"104","article-title":"Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.","volume-title":"Circulation","year":"2006"},{"key":"key_R03","first-page":"781","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.","volume":"324 (12)","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"key_R04","first-page":"24S","article-title":"A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.","volume":"15 (4 Suppl)","year":"2010","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"key_R05","first-page":"529","article-title":"Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia.","volume":"121 (7)","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"key_R06","first-page":"1317","article-title":"Short- and long-term effects of amiodarone on the two components of cardiac delayed rectifier K(+) current.","volume":"103 (9)","year":"2001","journal-title":"Circulation"},{"key":"key_R07","first-page":"1312","article-title":"Prescribing amiodarone: an evidence-based review of clinical indications.","volume":"298 (11)","year":"2007","journal-title":"JAMA"},{"key":"key_R08","first-page":"788","article-title":"Amiodarone: historical development and pharmacologic profile.","volume":"106 (4 Pt 2)","year":"1983","journal-title":"Am. Heart J."},{"key":"key_R09","first-page":"234","article-title":"Amiodarone-induced torsades de pointes.","volume":"7 (3)","year":"1986","journal-title":"Eur. Heart J."},{"key":"key_R10","first-page":"1250","article-title":"A practical guide for clinicians who treat patients with amiodarone: 2007.","volume":"4 (9)","year":"2007","journal-title":"Heart Rhythm"},{"key":"key_R11","first-page":"15","article-title":"Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?","volume":"25 (1)","year":"2008","journal-title":"Emerg Med J"},{"key":"key_R12","first-page":"77","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.","volume":"333 (2)","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"key_R13","first-page":"920","article-title":"Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications.","volume":"6 (10 Pt 2)","year":"1995","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"key_R14","first-page":"675","article-title":"Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.","volume":"349 (9053)","year":"1997","journal-title":"Lancet"},{"key":"key_R15","first-page":"667","article-title":"Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.","volume":"349 (9053)","year":"1997","journal-title":"Lancet"},{"key":"key_R16","first-page":"249","article-title":"The historical development, cellular electrophysiology and pharmacology of amiodarone.","volume":"31 (4)","year":"1989","journal-title":"Prog Cardiovasc Dis"},{"key":"key_R17","first-page":"791","article-title":"Adverse effects of low dose amiodarone: a meta-analysis.","volume":"30 (3)","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R18","first-page":"278","article-title":"Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.","volume":"44 (3)","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["Journal of Atrial Fibrillation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T18:30:56Z","timestamp":1513017056000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jafib.com\/published.php?type=full&id=1502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,10,31]]},"published-print":{"date-parts":[[2016]]}},"alternative-id":["10.4022\/jafib.1502"],"URL":"https:\/\/doi.org\/10.4022\/jafib.1502","relation":{},"ISSN":["1941-6911"],"issn-type":[{"type":"electronic","value":"1941-6911"}],"subject":[],"published":{"date-parts":[[2016]]},"article-number":"1502"}}